A 35-year-old woman with a 2-week history of hemoptysis, dyspnea, and hematuria (with RBC casts) presents with bilateral pulmonary infiltrates on chest X-ray and serum creatinine 2.8 mg/dL. Anti-GBM antibody serology is positive. Which investigation is most appropriate to confirm the diagnosis and assess disease severity in anti-GBM disease (Goodpasture syndrome)?

Explanation

## Diagnosis and Confirmation of Anti-GBM Disease ### Why Kidney Biopsy with IF is Definitive **Key Point:** Kidney biopsy with immunofluorescence microscopy showing linear IgG deposition along the glomerular basement membrane (GBM) is the gold standard for confirming anti-GBM disease and assessing the degree of crescentic involvement. ### Histopathologic Features of Anti-GBM Disease | Microscopy Type | Characteristic Finding | |---|---| | **Light Microscopy** | Crescentic GN (cellular, fibrocellular, or fibrous crescents); segmental necrosis; capillary wall disruption | | **Immunofluorescence** | **Linear IgG deposition** along the entire GBM (pathognomonic); often IgA, IgM, and C3 also present | | **Electron Microscopy** | Electron-lucent widening of GBM; no immune deposits ("pauci-immune") | **Clinical Pearl:** The linear IF pattern is virtually diagnostic of anti-GBM disease and distinguishes it from ANCA-associated vasculitis (which shows pauci-immune pattern) and immune complex GN (granular deposits). ### Why Biopsy Provides Both Diagnosis and Prognosis **High-Yield:** The percentage of crescents on biopsy is the strongest predictor of renal outcome and guides intensity of immunosuppression. - **<50% crescents:** Better prognosis; standard immunosuppression may suffice. - **>50% crescents or fibrous crescents:** Poor prognosis; aggressive therapy (plasmapheresis + cyclophosphamide + corticosteroids) required. ### Why Other Options Are Insufficient **Warning:** Serum anti-GBM antibody serology alone, though positive, does NOT assess glomerular involvement severity or the degree of crescentic disease. Biopsy is essential for prognostication. - **Serum/urine complement levels:** Complement is typically normal in anti-GBM disease (pauci-immune); complement depression suggests immune complex GN or ANCA-associated disease. - **Chest CT:** Assesses pulmonary involvement but does NOT confirm renal diagnosis or guide renal prognosis. - **Serum creatinine and eGFR trending:** Functional markers; do not provide histologic diagnosis or crescentic burden. ### Mnemonic for Crescentic GN Patterns **ANCA** — Pauci-immune (ANCA-associated vasculitis) **Anti-GBM** — Linear IgG (Goodpasture syndrome) **Immune Complex** — Granular deposits (lupus, PSGN, IgAN) **Tip:** In a patient with positive anti-GBM serology, biopsy is mandatory to quantify crescents and guide treatment intensity. Plasmapheresis is indicated if >50% crescents or if serum creatinine >5.6 mg/dL.